x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Decera Clinical Education Infectious Disease Podcast

Decera Clinical Education

Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Decera Clinical Education. Gain practical strategies and earn CME/CE credit for selected episodes.

education courses

All Episodes

00:04:50

Improving Access and Acceptance of HIV PrEP for...

Decera Clinical Education Infectious Disease Podcast ·

2022/12/20

In this episode, Carolyn Chu, MD, MSc, FAAFP, AAHIVS, discusses improving HIV pre-exposure prophylaxis accessibility and availability for PWID, including by:Integrating PrEP with services that PWID are already aware of and/or connected to (eg, harm reduction/syringe services and substance use disorder treatment programs, peer-based training/education initiatives, healthcare for the homeless programs, and emergency departments) Staffing PrEP programs with people who are trusted by PWID and delivering

en

00:54:40

Answering the Questions on Monkeypox in PWH

Decera Clinical Education Infectious Disease Podcast ·

2022/12/19

In this episode, Monica Gandhi, MD, MPH, and Chloe Orkin, MBChB, FRCP, MD, discuss considerations for monkeypox, now called mpox, in people with HIV, including:The history of monkeypox (mpox)The current monkeypox (mpox) outbreakWhat we knew about monkeypox (mpox) in PWH prior to the current outbreakData in PWH from an international case series of monkeypox (mpox)CDC data regarding monkeypox (mpox) in PWHMonkeypox (mpox) treatment recommendationsDrug–drug interaction considerations between

en

00:55:45

Answering the Questions on Considering an ART Switch...

Decera Clinical Education Infectious Disease Podcast ·

2022/12/19

In this episode, Annette Haberl, MD, and William R. Short, MD, MPH, AAHIVS, discuss when to consider an ART switch during pregnancy, including:Current DHHS, EACS, WHO, BHIVA, and German/Austrian guidelines for the use of ARVs in pregnancyWhat data and recommendations for the use of ARVs during pregnancy are currently missing from the guidelinesAvailable data on newer ARVs in the ARV pregnancy registryPharmacokinetic data for newer ARVs including BIC/FTC/TAF and LA CAB + RPV in

en

00:11:43

Expanding Access to Long-Acting ART in Europe

Decera Clinical Education Infectious Disease Podcast ·

2022/12/19

In this episode, Stephane De Wit, MD, PhD, discusses the benefits of long-acting antiretroviral therapy (ART) for migrant populations in Europe—and specifically in Belgium. He also addresses some of the challenges of accessing and following up with those populations.Dr De Wit describes some of the ways that the Belgian healthcare system is set up to improve access to ART. He then explains some of the disease parameters for considering expanding the use of long-acting ART to patients who are not

en

00:13:28

Whom to Screen for Hepatitis Delta Virus

Decera Clinical Education Infectious Disease Podcast ·

2022/12/15

In this episode, Nancy Reau, MD, and Coleman I. Smith, MD, discuss the burden of undiagnosed hepatitis delta virus (HDV) infection and who should be tested, including:Epidemiology of HDV infectionClinical course of HDV infectionPopulations at high risk of HDV infectionGuidelines for HDV testingFaculty: Nancy Reau, MDProfessor of MedicineChief, Section of Hepatology Associate Director, Solid Organ Transplantation Richard B. Capps Chair of HepatologyRush University Medical CenterChicago,

en

00:12:38

Hong Kong Perspective: Should Older Age Influence...

Decera Clinical Education Infectious Disease Podcast ·

2022/12/15

When it comes to managing adults with HBV, should age factor into your treatment decision—or is it important to treat everyone, regardless of age?Listen as Dr George Lau discusses these questions and more for strategizing the monitoring and treatment of older adults with HBV. Presenter: George Lau, MBBS (HKU), MD (HKU), FRCP (Edin, Lond), FAASLD (USA)ChairmanHumanity and Health Medical GroupHong Kong, ChinaChair, Professor, and Co-DirectorLiver Diseases & Transplant CentreThe Fifth Medical Centre of

en

00:33:33

What Patients Want in HIV Treatment and Prevention:...

Decera Clinical Education Infectious Disease Podcast ·

2022/12/14

In this episode, Winnie Sseruma and Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD, discuss some of the barriers to genuinely patient-centered HIV care in Africa and offer calls to action for healthcare professionals for responding to patient preferences.They discuss the efforts to improve patient-centered HIV care in the foundations and organizations for which they work. They also address issues related to stigma around HIV and complacency and lack of visibility for HIV.You will then hear them

en

00:37:59

What Patients Want in HIV Treatment and Prevention:...

Decera Clinical Education Infectious Disease Podcast ·

2022/12/07

In this episode, Iskandar Azwa, MBChB, and patient advocate Andrew Tan Tze Tho discuss barriers to genuinely patient-centered HIV care in Malaysia and the surrounding region and offer calls to action for healthcare professionals for responding to patient preferences.They discuss health literacy programs and other forms of effective health communication, especially with respect to disparate communities. They also address the prevalence of late presentation in Malaysia and the importance of getting

en

00:18:01

Addressing ART Safety and Tolerability in Transgender...

Decera Clinical Education Infectious Disease Podcast ·

2022/12/07

In this episode, Jill Blumenthal, MD, MAS, and Jennifer Cocohoba, PharmD, share how they manage possible antiretroviral (ARV)-associated toxicities in transgender individuals, including:Strategies on how to approach different ARV-related toxicitiesOther factors to consider when assessing possible ARV-related toxicities (eg, weight gain, cardiovascular disease), such as gender-affirming care and nonmedication risk factors (eg, smoking, life stressors)Clinically relevant drug–drug interactions related

en

00:30:47

FAQs: Improving Empiric Antibiotic Regimens for...

Decera Clinical Education Infectious Disease Podcast ·

2022/12/06

In this episode, Marion Elligsen, BScPhm, MSc, RPh, ACPR; Keith S Kaye, MD, MPH; and Andrew Shorr, MD, MPH, MBA, discuss key considerations for selecting empiric antibiotic regimens in patients with HABP/VABP in the intensive care unit, including: The role of novel β-lactam/β-lactamase inhibitor combinationsUse of clinical predictions scores (eg, Drug Resistance in Pneumonia [DRIP] score) to predict risk for pneumonia caused by multidrug-resistant pathogensApplication of rapid diagnostic testing in

en

00:41:00

Newest Viral Hepatitis Data From AASLD 2022

Decera Clinical Education Infectious Disease Podcast ·

2022/12/06

In this episode, Stefan Zeuzem, MD, discusses new viral hepatitis data from AASLD 2022, including:Hepatitis BPrevention of HBV vertical transmission when HBIg is unavailableTherapeutic vaccination for HBV cureAntiviral therapy to prevent HCC in patients with CHB in the indeterminate phaseHepatitis deltaHDV prevalence in ethnically diverse, urban, safety-net populationsBulevirtide ± pegIFN-α2a for chronic HDV in the French cATU studyBulevirtide monotherapy for patients with HDV and compensated

en

00:08:05

Practice-Changing Viral Hepatitis Data From AASLD 2022

Decera Clinical Education Infectious Disease Podcast ·

2022/12/06

In this episode, Nancy Reau, MD, shares her thoughts on the most practice-changing viral hepatitis data from AASLD 2022, including:Novel therapeutics for HBVHCV management strategiesHDV screening and linkage to careFatty liver disease in persons with viral hepatitisUse of statins to decrease morbidity and mortality in persons with liver diseasePresenter:Nancy Reau, MDProfessor of MedicineChief, Section of HepatologyAssociate DirectorSolid Organ TransplantationRichard B. Capps Chair of HepatologyRush

en

00:38:29

Key HIV Studies Influencing My Practice Following...

Decera Clinical Education Infectious Disease Podcast ·

2022/12/05

In this episode, Chloe Orkin, MBChB, FRCP, MD, and Babafemi Taiwo, MBBS, discuss new HIV data presented at IDWeek and HIV Glasgow 2022, includingPrevention strategiesLA therapiesInvestigational agentsPresenters:Chloe Orkin, MBChB, FRCP, MDProfessor of HIVQueen Mary, University of LondonConsultant PhysicianLead for HIV ResearchBarts Health NHS TrustThe Royal London HospitalLondon, United KingdomBabafemi Taiwo, MBBSGene Stollerman Professor of MedicineChief, Division of Infectious

en

00:46:40

COVID-19 Antiviral Agents and COVID-19 Rebound

Decera Clinical Education Infectious Disease Podcast ·

2022/11/22

In this episode, Jason Gallagher, PharmD, and Emily Heil, PharmD, MS, BCIDP discuss landmark clinical trials of COVID-19 antivirals for nonhospitalized patients and COVID-19 rebound phenomenon, including: EPIC-HR study of nirmatrelvir plus ritonavirPINETREE study of remdesivirMOVe-OUT and Panoramic studies of molnupiravirCOVID-19 rebound in treated and untreated patientsPresenters:Jason Gallagher, PharmDClinical ProfessorSchool of PharmacyTemple UniversityClinical Pharmacy SpecialistInfectious

en

00:37:17

Key COVID-19 Studies Influencing My Practice...

Decera Clinical Education Infectious Disease Podcast ·

2022/11/18

In this episode, Princy N. Kumar, MD, and Paul E. Sax, MD, discuss new COVID-19 data from IDWeek 2022, including:COVID-19 vaccines, including omicron BA.1 bivalent boosterRisk factors for breakthrough COVID-19 infectionsCOVID-19 diagnostics, including digital droplet PCRCOVID-19 therapeutics, including:Nirmatrelvir plus ritonavirTixagevimab plus cilgavimabBaricitinibTocilizumabInhaled interferon β-1aCOVID-19 therapeutics and outcomes in patients with immunocompromiseLong COVIDPresenters:Princy N

en

00:16:58

Creative Strategies for Meningococcal Vaccine Uptake

Decera Clinical Education Infectious Disease Podcast ·

2022/11/17

In this episode, Nneka Holder, MD, MPH, shares various strategies to improve meningococcal vaccine uptake in adolescent patients, including: Use of school vaccine mandates beyond entry requirementsPromote more frequent visits by incorporating immunization platforms and using text or email reminders to bring patients back to the officeSchedule follow-up visits before patients leave the office to increase retentionIncrease access and convenience by:Implementing quick, immunization-only visitsPromoting

en

00:10:59

Barriers and Solutions to Expanding PrEP Uptake:...

Decera Clinical Education Infectious Disease Podcast ·

2022/11/15

This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses solutions to expanding PrEP uptake. His discussion includes: Potential healthcare professional barriers to prescribing PrEPAddressing the gap in PrEP training for healthcare professionalsExpanding PrEP options to facilitate adherence and

en

00:04:52

Barriers and Solutions to Expanding PrEP Uptake:...

Decera Clinical Education Infectious Disease Podcast ·

2022/11/15

This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, focuses on transgender women. His discussion includes: Barriers to PrEP uptake in transgender womenHigh PrEP adherence among transgender women and transfeminine individuals in a real-world healthcare setting in New York CityPresenter: Timothy J

en

00:04:50

Barriers and Solutions to Expanding PrEP Uptake:...

Decera Clinical Education Infectious Disease Podcast ·

2022/11/15

This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses barriers to PrEP uptake for people who inject drugs. His discussion includes: PrEP uptake and recommendations for people who inject drugsProject SHE: integrating PrEP with community-based syringe services for women who inject

en

00:07:21

Barriers and Solutions to Expanding PrEP Uptake:...

Decera Clinical Education Infectious Disease Podcast ·

2022/11/15

This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses PrEP uptake for cisgender women. His discussion includes: Prevalence of PrEP use in cisgender women in the United StatesBarriers to PrEP uptake in cisgender womenImplementation of PrEP within family planning clinics in AtlantaPrEP in

en

497 results

Similar Podcasts

Science Talk

Albert Einstein College of Medicine

五分钟心理学

柠檬心理

Daily Facts

Amalia Dupray and Montgomery Jones.

Les dents et dodo

BFMTV

Veterinary Clinical Podcasts

The Royal Veterinary College